Density Functional Theory and Molecular Simulation Studies for Prioritizing Anaplastic Lymphoma Kinase Inhibitors.

Area of Science:

• Computational chemistry
• Drug discovery
• Oncology

Background:

• Targeting anaplastic lymphoma kinase (ALK) is a key strategy in non-small cell lung cancer (NSCLC) therapy.
• Developing novel ALK inhibitors requires advanced computational screening and validation methods.

Purpose of the Study:

• To identify novel ALK inhibitors using a multidimensional computational approach.
• To evaluate the potential efficacy and safety of identified compounds for NSCLC treatment.

Main Methods:

• Generation of an e-pharmacophore model and screening of the ASINEX database.
• Hierarchical docking, binding free energy calculations, and ADMET property prediction.
• Density functional theory and molecular dynamics simulations for validation.

Main Results:

• Two lead compounds, BAS 00137817 and BAS 00680055, were identified with high affinity for ALK.
• These compounds demonstrated acceptable absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles.
• Identified scaffolds are crucial for downregulating ALK-positive lung cancer pathways.

Conclusions:

• The study successfully identified novel ALK inhibitors with potential for NSCLC treatment.
• The findings support the rational design of new, effective ALK inhibitors.
• Computational approaches are valuable for accelerating drug discovery in oncology.